{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:51:03Z","timestamp":1788389463675,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0597"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0597"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372807"],"award-info":[{"award-number":["82372807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.intimp.2026.116180","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:35:21Z","timestamp":1768451721000},"page":"116180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["miR-let-7a suppresses gastric cancer peritoneal metastasis through IRS2-mediated M1 macrophage polarization and direct inhibition of gastric cancer cells"],"prefix":"10.1016","volume":"172","author":[{"given":"Mengyuan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.intimp.2026.116180_bb0010","first-page":"717","article-title":"Chinese expert consensus on the diagnosis and treatment of peritoneal metastasis of gastric cancer (2023 edition)","volume":"26","author":"G.C.C.O.C.A.C. Association","year":"2023","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"32","key":"10.1016\/j.intimp.2026.116180_bb0015","doi-asserted-by":"crossref","first-page":"52307","DOI":"10.18632\/oncotarget.10740","article-title":"Metastatic spread in patients with gastric cancer","volume":"7","author":"Riihim\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.intimp.2026.116180_bb0020","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","article-title":"Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy","volume":"24","author":"Ikoma","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-020-20429-0","article-title":"Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejso.2022.08.023","article-title":"Clinical epidemiology of peritoneal metastases in China: the construction of professional peritoneal metastases treatment centers based on the prevalence rate","volume":"49","author":"Yang","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"23","key":"10.1016\/j.intimp.2026.116180_bb0035","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116180_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103681","article-title":"Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes","volume":"9","author":"Sundar","year":"2024","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1186\/s12885-020-07601-x","article-title":"Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0050","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12885-025-14206-9","article-title":"Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2026.116180_bb0055","article-title":"Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: a retrospective real-world study","volume":"12","author":"Xiang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116180_bb0060","article-title":"Response efficacy of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.intimp.2026.116180_bb0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2026.116180_bb0080","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116180_bb0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1248\/bpb.29.903","article-title":"Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells","volume":"29","author":"Akao","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.intimp.2026.116180_bb0090","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1158\/1078-0432.CCR-07-4667","article-title":"Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family","volume":"14","author":"Motoyama","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.intimp.2026.116180_bb0095","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4161\/cc.8.6.7907","article-title":"Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression","volume":"8","author":"Peter","year":"2009","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0105","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13046-020-01813-6","article-title":"Let-7a regulates EV secretion and mitochondrial oxidative phosphorylation by targeting SNAP23 in colorectal cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"52","key":"10.1016\/j.intimp.2026.116180_bb0115","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1038\/onc.2008.282","article-title":"Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma","volume":"27","author":"M\u00fcller","year":"2008","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.intimp.2026.116180_bb0120","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.21873\/anticanres.17346","article-title":"Let-7a and let-7b as potential signatures for glioma recurrence, regardless of WHO tumor grade","volume":"44","author":"Weber","year":"2024","journal-title":"Anticancer Res."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2026.116180_bb0125","article-title":"ASAP1 protein macromolecule promotes the growth and development of gastric cancer cells and the remodeling of F-actin cytoskeleton: expression of VEGF and HIF-1 \u03b1 proteins","volume":"315","author":"Gao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116180_bb0130","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2009.11.007","article-title":"The chemokine system in cancer biology and therapy","volume":"21","author":"Mantovani","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0140","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","article-title":"Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression","volume":"11","author":"De Boeck","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.29376","article-title":"Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment","volume":"137","author":"S\u00e9galiny","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13045-021-01198-9","article-title":"Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers","volume":"14","author":"Xu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116180_bb0165","first-page":"557","article-title":"Research progress on peritoneal metastasis of gastric cancer in the era of immunotherapy","volume":"28","author":"Yang","year":"2025","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.intimp.2026.116180_bb0170","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3389\/fimmu.2019.02002","article-title":"Macrophage rewiring by nutrient associated PI3K dependent pathways","volume":"10","author":"Sharif","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116180_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biochi.2017.04.002","article-title":"Alkaline pH induces IRR-mediated phosphorylation of IRS-1 and actin cytoskeleton remodeling in a pancreatic beta cell line","volume":"138","author":"Deyev","year":"2017","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.intimp.2026.116180_bb0185","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","article-title":"Phosphorylation of IRS proteins, insulin action, and insulin resistance","volume":"296","author":"Boura-Halfon","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0190","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/s41467-018-07358-9","article-title":"Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity","volume":"9","author":"Kubota","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.116180_bb0195","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00125-017-4330-3","article-title":"The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity","volume":"60","author":"Vinu\u00e9","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2026.116180_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molmet.2018.11.010","article-title":"Deletion of myeloid IRS2 enhances adipose tissue sympathetic nerve function and limits obesity","volume":"20","author":"Rached","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.intimp.2026.116180_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaf028","article-title":"IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategies","author":"Greenberg","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"Pt 4","key":"10.1016\/j.intimp.2026.116180_bb0210","article-title":"Long non-coding RNA LINC01232 promotes malignancy of prostate cancer through regulation of miR-181a-5p\/IRS2 pathway: Ki-67 protein molecular structure and function","volume":"306","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116180_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111759","article-title":"The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2\/PI3K-mediated regulation of MYC","volume":"41","author":"Lee","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cmi.2013.51","article-title":"MicroRNA-let-7a promotes E2F-mediated cell proliferation and NF\u03baB activation in vitro","volume":"11","author":"Chafin","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.116180_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1598306","article-title":"MicroRNAs regulate alveolar macrophage homeostasis and its function in lung fibrosis","volume":"16","author":"Parajuli","year":"2025","journal-title":"Front. Immunol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2026.116180_bb0230","article-title":"LncRNA H19-mediated M2 polarization of macrophages promotes myofibroblast differentiation in pulmonary fibrosis induced by arsenic exposure","volume":"268","author":"Xiao","year":"2021","journal-title":"Environ. Pollut."},{"issue":"48","key":"10.1016\/j.intimp.2026.116180_bb0235","doi-asserted-by":"crossref","first-page":"24922","DOI":"10.1074\/jbc.M116.756791","article-title":"The TORC1-activated proteins, p70S6K and GRB10, regulate IL-4 signaling and M2 macrophage polarization by modulating phosphorylation of insulin receptor substrate-2","volume":"291","author":"Warren","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2026.116180_bb0240","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1111\/cas.15545","article-title":"Effectiveness of endoscopic screening for gastric cancer: the Japan public health center-based prospective study","volume":"113","author":"Narii","year":"2022","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0245","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2017.01.029","article-title":"Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality","volume":"152","author":"Jun","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17010117","article-title":"Emerging trends in the management of gastric malignancy with peritoneal dissemination: same disease, heterogeneous prognosis","volume":"17","author":"Mela","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.116180_bb0255","article-title":"The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art","volume":"2014","author":"Montori","year":"2014","journal-title":"Int. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0260","first-page":"49","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.intimp.2026.116180_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s44321-023-00012-y","article-title":"Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer","volume":"16","author":"Che","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0270","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3892\/ijo_00000795","article-title":"Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model","volume":"37","author":"Kawaguchi","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0275","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10294","key":"10.1016\/j.intimp.2026.116180_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2026.116180_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007927","article-title":"Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells","volume":"12","author":"Botta","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.116180_bb0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ags3.12515","article-title":"International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1)","volume":"6","author":"Yoshida","year":"2022","journal-title":"Ann Gastroenterol Surg"},{"issue":"44","key":"10.1016\/j.intimp.2026.116180_bb0295","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1038\/onc.2011.154","article-title":"IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer","volume":"30","author":"Jiang","year":"2011","journal-title":"Oncogene"},{"issue":"38","key":"10.1016\/j.intimp.2026.116180_bb0300","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","article-title":"Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling","volume":"40","author":"Du","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","article-title":"Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.intimp.2026.116180_bb0310","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1349-7006.2000.tb01004.x","article-title":"A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasis","volume":"91","author":"Nishimori","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116180_bb0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10555-025-10265-3","article-title":"Molecular mechanisms of metastatic peritoneal dissemination in gastric adenocarcinoma","volume":"44","author":"Ng","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0320","first-page":"687","article-title":"Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice","volume":"53","author":"Hagiwara","year":"1993","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4149\/neo_2011_01_20","article-title":"Omental milky spots in screening gastric cancer stem cells","volume":"58","author":"Cao","year":"2011","journal-title":"Neoplasma"},{"issue":"12","key":"10.1016\/j.intimp.2026.116180_bb0330","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/stem.1816","article-title":"Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem\/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1\u03b1","volume":"32","author":"Miao","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2026.116180_bb0335","first-page":"11","article-title":"The natural history of free cancer cells in the peritoneal cavity","volume":"169","author":"Yonemura","year":"2007","journal-title":"Recent Results Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00441-002-0636-6","article-title":"Biodefense function of omental milky spots through cell adhesion molecules and leukocyte proliferation","volume":"310","author":"Cui","year":"2002","journal-title":"Cell Tissue Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.116180_bb0345","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s12276-020-00538-y","article-title":"Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer","volume":"52","author":"Eum","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2012.03.029","article-title":"miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3","volume":"323","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"issue":"42","key":"10.1016\/j.intimp.2026.116180_bb0355","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/onc.2011.581","article-title":"MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers","volume":"31","author":"Zheng","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.intimp.2026.116180_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130472","article-title":"Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer","volume":"10","author":"Tokuhisa","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2026.116180_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030085","article-title":"Principles of microRNA-target recognition","volume":"3","author":"Brennecke","year":"2005","journal-title":"PLoS Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116180_bb0370","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/jcmm.12861","article-title":"The insights of Let-7 miRNAs in oncogenesis and stem cell potency","volume":"20","author":"Sun","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116180_bb0375","article-title":"Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.116180_bb0380","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116180_bb0385","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1186\/s12885-016-2904-y","article-title":"Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway","volume":"16","author":"Jin","year":"2016","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.intimp.2026.116180_bb0390","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00590-17","article-title":"Identification of a novel invasion-promoting region in insulin receptor substrate 2","volume":"38","author":"Mercado-Matos","year":"2018","journal-title":"Mol. Cell. Biol."},{"issue":"39","key":"10.1016\/j.intimp.2026.116180_bb0395","doi-asserted-by":"crossref","first-page":"20574","DOI":"10.1074\/jbc.M116.746164","article-title":"Suppressor of cytokine signaling (SOCS)1 regulates interleukin-4 (IL-4)-activated insulin receptor substrate (IRS)-2 tyrosine phosphorylation in monocytes and macrophages via the proteasome","volume":"291","author":"McCormick","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.intimp.2026.116180_bb0400","first-page":"28527","article-title":"Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells","volume":"270","author":"Johnston","year":"1995","journal-title":"Potential role of JAK kinases, J Biol Chem"},{"issue":"10","key":"10.1016\/j.intimp.2026.116180_bb0405","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1074\/jbc.272.10.6556","article-title":"Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116180_bb0410","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3389\/fimmu.2018.01037","article-title":"IL-4 and IL-13 receptor signaling from 4PS to insulin receptor substrate 2: there and back again, a historical view","volume":"9","author":"Keegan","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116180_bb0415","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/ptr.8146","article-title":"Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K\/AKT pathway","volume":"38","author":"Wu","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.116180_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148268","article-title":"Brain abundant membrane attached signal protein 1 regulates macrophage polarization through EGFR\/PI3K\/AKT signaling in renal cell carcinoma","author":"Jin","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0425","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.21873\/invivo.11669","article-title":"Establishment of peritoneal and hepatic metastasis mouse xenograft models using gastric cancer cell lines","volume":"33","author":"Miwa","year":"2019","journal-title":"In Vivo"},{"issue":"2","key":"10.1016\/j.intimp.2026.116180_bb0430","first-page":"205","article-title":"Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide","volume":"20","author":"Yonemura","year":"2001","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116180_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104601","article-title":"Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions","volume":"92","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0440","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4161\/cc.7.6.5834","article-title":"The let-7 microRNA reduces tumor growth in mouse models of lung cancer","volume":"7","author":"Esquela-Kerscher","year":"2008","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.intimp.2026.116180_bb0445","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"Let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:58:10Z","timestamp":1771520290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":89,"alternative-id":["S1567576926000238"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116180","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-let-7a suppresses gastric cancer peritoneal metastasis through IRS2-mediated M1 macrophage polarization and direct inhibition of gastric cancer cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116180"}}